default author photo

Don Gibbons

University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

205

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Deep Learning CT Signature Predicts Benefit from Immunotherapy in Metastatic NSCLC Independent of Standard Clinicopathological Markers

Number of pages: 32 Posted: 13 Jun 2022
University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, Stanford University - Department of Medicine, Stanford University - Department of Medicine, Baylor College of Medicine, Baylor University - Department of Medicine Epidemiology and Population Science, New York University (NYU) - Thoracic Oncology Program, Harvard University - Department of Radiology, Mayo Clinic - Florida - Division of Hematology and Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center - Department of Biostatistics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and Stanford University - Department of Radiation Oncology
Downloads 97 (704,534)

Abstract:

Loading...

Non-small cell lung cancer (NSCLC), Immune Checkpoint Inhibitors (ICIs), Imaging biomarkers, Computed Tomography (CT), Deep learning, Survival analysis

2.

Allergic Mediator Histamine Confers Immunotherapy Resistance in Cancer Patients via Histamine Receptor 1 on Macrophage

Number of pages: 70 Posted: 18 Nov 2020
The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center – Clinical Informatics Specialist, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Juntendo University School of Medicine – Department of Immunology, Harbin Medical University Cancer Hospital - Department of Breast Surgery, Chongqing Medical University - Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The University of Texas MD Anderson Cancer Center - Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center - Department of Biostatistics and The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology
Downloads 67 (899,324)

Abstract:

Loading...

Histamine, HRH1, allergy, antihistamines, macrophage, cancer, T-cell, anti-tumor immunity, immunotherapy

3.

Contextual Cues from Cancer Cells Govern CAF Heterogeneity

Number of pages: 51 Posted: 23 Apr 2020
University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Baylor College of Medicine - Department of Molecular and Human Genetics, Baylor College of Medicine - Department of Molecular and Human Genetics, University of Texas at Houston, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Baylor College of Medicine - Department of Molecular and Human Genetics, Baylor College of Medicine - Department of Molecular and Human Genetics, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, Rice University - Department of Bioengineering, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Independent, University of Texas at Houston - Department of Translational Molecular Pathology, Baylor College of Medicine - Division of Biostatistics, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, Rice University - Department of Bioengineering, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, Washington University in St. Louis - Department of Medicine, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston, UCSF Cardiovascular Research Institute, Rice University - Department of Bioengineering, Baylor College of Medicine - Department of Molecular and Human Genetics and University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology
Downloads 41 (1,170,409)

Abstract:

Loading...

cancer associated fibroblasts, lung adenocarcinoma, Single Cell Sequencing, EMT, ZEB1